Bausch + Lomb Files Registration Statement for Proposed IPO

By
ROCHESTER, N.Y.—Global eye health company Bausch + Lomb announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC), through its holding company WP Prism, relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed maximum aggregate offering price is $100 million according to the SEC filing.

Bausch+Lomb is owned by Warburg Pincus, which took it private in 2007 for about $4.5 billion, including $830 million of debt. For the year ending Dec. 29, 2012, Bausch+Lomb posted sales of $3.0 billion, a net loss of $68.3 million and adjusted EBITDA of $643.1 million.

According to a leading independent consulting firm cited in the SEC filing, the global eye health market will grow from $36 billion of sales in 2011 to more than $48 billion of sales in 2017, at a compound annual growth rate of approximately 5 percent, the filing noted.

J.P.Morgan, BofA Merrill Lynch and Citigroup were the lead underwriters of the offering, according to the SEC filing.

Founded in 1853, Bausch+Lomb is headquartered in Rochester, N.Y., and employs more than 11,000 people worldwide.